![](/img/cover-not-exists.png)
A randomized, double-blind, placebo-controlied trial of subcutaneous etanercept (p75 souble tumor necrosis factor: FC fusion protein) in the treatment of moderate to severe Crohns' disease
William J. Sandborn, Stephen B. Hanauer, Seymour Katz, Michael Safdi, Daouglas C. Wolf, Richard D. Baerg, William J. Tremaine, Therese Johnson, Nancy Diehl, Alan R. ZinsmeisterVolume:
120
Year:
2001
Language:
english
DOI:
10.1016/s0016-5085(08)80100-x
File:
PDF, 184 KB
english, 2001